Inclusion Body Myositis
📧 Sign up to get email alerts when something new happens for Inclusion Body Myositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies [NA]
A completed clinical trial evaluating the diagnostic accuracy of whole-body magnetic resonance imaging for detecting inflammatory myopathies…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis [Phase 2, Phase 3]
A completed Phase 2/3 study evaluating the efficacy and safety of ABC008 for inclusion body myositis.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells [NA]
A clinical trial evaluating Celution-processed adipose-derived regenerative cells for Inclusion Body Myositis has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis [Phase 2, Phase 3]
Clinical trial comparing rapamycine to placebo for inclusion body myositis has completed (Phase 2/Phase 3); no efficacy results are provided…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Exercise as Treatment for Patients With Inclusion Body Myositis [NA]
A feasibility study assessing exercise as a treatment for Inclusion Body Myositis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With (IBM) [Phase 1]
The Phase 1 SAD/MAD study of ABC008 in Inclusion Body Myositis has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis [Phase 1]
Phase 1 trial update reporting safety and tolerability data for phenylbutyrate in Inclusion Body Myositis, with the study status shown as co…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: The Risk of Falls Index for Patients With Neuromuscular Disorders
A completed trial evaluating a Falls Index to assess fall risk in patients with neuromuscular disorders, including Inclusion Body Myositis, …
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial [Phase 3]
Open-label extension phase 3 trial of arimoclomol in sporadic inclusion body myositis has terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Study of Arimoclomol in Inclusion Body Myositis (IBM) [Phase 2]
Phase 2 clinical trial of arimoclomol in Inclusion Body Myositis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Arimoclomol in Sporadic Inclusion Body Myositis [Phase 2, Phase 3]
This document reports an update on a Phase 2/3 trial of arimoclomol for sporadic Inclusion Body Myositis, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis [EARLY_Phase 1]
This EARLY Phase 1 double-blind, randomized, placebo-controlled trial evaluated etanercept for 12 months in individuals with inclusion body …
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis
A completed clinical trial evaluating muscle strength and inflammatory response in patients with inclusion body myositis is reported.
-
CLINICAL_TRIALS trial_result · 2010-07-19Clinical Trial Update: Anakinra in Myositis [Phase 2, Phase 3]
Karolinska Institutet-sponsored Phase 2 and Phase 3 trials evaluated anakinra for polymyositis and dermatomyositis (myositis), with inclusio…
-
CLINICAL_TRIALS trial_result · 2010-06-17Clinical Trial Update: Alemtuzumab to Treat Sporadic Inclusion Body Myositis [Phase 2]
A Phase 2 trial evaluating alemtuzumab for inclusion body myositis has completed; the snippet does not provide trial results.
-
CLINICAL_TRIALS trial_result · 2010-02-26Clinical Trial Update: Lithium in Inclusion Body Myositis (IBM)
This document reports the completion of a clinical trial evaluating lithium for Inclusion Body Myositis (IBM).
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies [Phase 2]
Phase 2 clinical trial evaluating intravenous immunoglobulin for inflammatory myopathies, including dermatomyositis, polymyositis, and inclu…